Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Hansa Biopharma AB

Closing information (x1000 NOK)

Closing information 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 146,167 Less Arrow 33,039 Less Arrow 6,388
Financial expenses 46,008 Less Arrow 1,189 Less Arrow 269
Earnings before taxes -576,987 More Arrow -534,549 More Arrow -440,928
EBITDA -556,753 More Arrow -533,425 More Arrow -434,902
Total assets 1,596,139 Less Arrow 987,713 More Arrow 1,502,780
Current assets 1,517,910 Less Arrow 918,993 More Arrow 1,459,714
Current liabilities 250,396 Less Arrow 166,977 Less Arrow 119,639
Equity capital 570,301 More Arrow 738,802 More Arrow 1,301,251
- share capital 52,057 Less Arrow 45,187 Less Arrow 43,421
Employees (average) 144 Less Arrow 116 Less Arrow 82

Financial ratios

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency 35.7% More Arrow 74.8% More Arrow 86.6%
Turnover per employee 1,015 Less Arrow 285 Less Arrow 78
Profit as a percentage of turnover -394.7% Less Arrow -1617.9% Less Arrow -6902.4%
Return on assets (ROA) -33.3% Less Arrow -54.0% More Arrow -29.3%
Current ratio 606.2% Less Arrow 550.4% More Arrow 1220.1%
Return on equity (ROE) -101.2% More Arrow -72.4% More Arrow -33.9%
Change turnover 114,122 Less Arrow 27,092 Less Arrow 2,864
Change turnover % 356% More Arrow 456% Less Arrow 81%
Chg. No. of employees 28 More Arrow 34 Less Arrow 19
Chg. No. of employees % 24% More Arrow 41% Less Arrow 30%

Total value of public sale

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.